Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05218447 · ClinicalTrials.gov registry record · NA

Dosing of Overground Robotic Gait Training with Functional Outcomes and Neuroplasticity After Spinal Cord Injury

A NA study of Spinal Cord Injuries, sponsored by Baylor Research Institute.

Recruiting
Registry status
NA
Development phase
144
Enrollment target
1
Study location

NCT05218447 is a NA study of Spinal Cord Injuries that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 144 participants, above the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (136% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05218447, a NA study of Spinal Cord Injuries, is actively recruiting participants, sponsored by Baylor Research Institute.

RECRUITING
Registry status
NA
Development phase
144 participants
Enrollment target
1
Study location

Study Summary

The DOOR SCI project examines dosing effects of robotic gait training (RGT) and transcranial magnetic stimulation (TMS) initiated during inpatient rehabilitation and continued through early outpatient rehabilitation

Conditions Studied

Interventions

  • DEVICE Robotic Gait Training
  • OTHER Usual Care (UC) Gait Training

Study Locations (1)

Texas

  • Baylor Scott & White Institute for Rehabilitation - Dallas

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2022-05-20
Est. Completion 2025-09-14
Phase NA

Sponsor

Baylor Research Institute

180 total trials

What the Registry Record Tells You About NCT05218447

The ClinicalTrials.gov registry entry for NCT05218447 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (136% higher). The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Spinal Cord Injuries appearing as the primary indexed condition, and to 2 interventions - of which Robotic Gait Training is the first listed.

NCT05218447 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05218447 about?

NCT05218447 is a clinical study titled "Dosing of Overground Robotic Gait Training with Functional Outcomes and Neuroplasticity After Spinal Cord Injury". The DOOR SCI project examines dosing effects of robotic gait training (RGT) and transcranial magnetic stimulation (TMS) initiated during inpatient rehabilitation and continued through early outpatient rehabilitation

What is the current status of trial NCT05218447?

This trial is currently recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2022-05-20. Estimated completion is 2025-09-14.

What conditions does trial NCT05218447 study?

This clinical trial studies the following conditions: Spinal Cord Injuries.

What interventions are being tested in trial NCT05218447?

The interventions under investigation include: Robotic Gait Training (DEVICE), Usual Care (UC) Gait Training (OTHER).

Who is sponsoring clinical trial NCT05218447?

This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05218447 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.